-
Start Preamble
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Final rule.
SUMMARY:
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect that the conditional approval of an application for masitinib mesylate tablets, a new animal drug for a minor use, is no longer in effect.
DATES:
This rule is effective January 21, 2016.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
George K. Haibel, Center for Veterinary Medicine (HFV-6), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-402-5689, george.haibel@fda.hhs.gov.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
FDA is amending the animal drug regulations to reflect that application 141-308 for conditional approval of KINAVET-CA1 (masitinib mesylate) Tablets, a new animal drug for a minor use sponsored by AB Science, 3 Avenue George V, 75008 Paris, France, is no longer in effect.
Elsewhere in this issue of the Federal Register, FDA gave notice that conditional approval of this drug, by operation of law, was no longer in effect as of December 15, 2015.
This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.
Start List of SubjectsList of Subjects
21 CFR Part 510
- Administrative practice and procedure
- Animal drugs
- Labeling
- Reporting and recordkeeping requirements
21 CFR Part 516
- Administrative practice and procedure
- Animal drugs
- Confidential business information
- Reporting and recordkeeping requirements
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510 and 516 are amended as follows:
Start PartPART 510—NEW ANIMAL DRUGS
End Part Start Amendment Part1. The authority citation for 21 CFR part 510 continues to read as follows:
End Amendment Part[Amended]2. In § 510.600, in the table in paragraph (c)(1), remove the entry for “AB Science” and in the table in paragraph (c)(2), remove the entry for “052913”.
End Amendment Part Start PartPART 516—NEW ANIMAL DRUGS FOR MINOR USE AND MINOR SPECIES
End Part Start Amendment Part3. The authority citation for 21 CFR part 516 continues to read as follows:
End Amendment Part[Removed]4. Remove § 516.1318.
End Amendment Part Start SignatureDated: January 14, 2016.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
[FR Doc. 2016-01100 Filed 1-20-16; 8:45 am]
BILLING CODE 4164-01-P
Document Information
- Effective Date:
- 1/21/2016
- Published:
- 01/21/2016
- Department:
- Food and Drug Administration
- Entry Type:
- Rule
- Action:
- Final rule.
- Document Number:
- 2016-01100
- Dates:
- This rule is effective January 21, 2016.
- Pages:
- 3324-3324 (1 pages)
- Docket Numbers:
- Docket No. FDA-2015-N-0002
- Topics:
- Administrative practice and procedure, Animal drugs, Confidential business information, Labeling, Reporting and recordkeeping requirements
- PDF File:
- 2016-01100.pdf
- Supporting Documents:
- » FONSI for sN 141-361, approved December 7, 2015
- » FONSI for oN 141-453, approved December 8, 2015
- » FOI Summary for sN 141-361, approved December 7, 2015
- » FOI Summary for sN 141-258, approved December 2, 2015
- » FOI Summary for oN 141-453, approved December 8, 2015
- » EA for sN 141-361, approved December 7, 2015
- » EA for oN 141-453, approved December 8, 2015
- » Finding of No Significant Impact (FONSI) for SAFE-GUARD AQUASOL (fenbendazole oral suspension) in Chickens
- » FREEDOM OF INFORMATION SUMMARY NADA 141-442 LUTALYSE HighCon Injection Dinoprost Tromethamine Injection Lactating dairy cows, beef cows, beef heifers, and replacement dairy heifers
- » FREEDOM OF INFORMATION SUMMARY NADA 141-449 SAFE-GUARD AquaSol Fenbendazole oral suspension Broiler chickens, replacement chickens intended to become breeding chickens, and breeding chickens
- CFR: (2)
- 21 CFR 510.600
- 21 CFR 516.1318